Table 1.
Characteristics | N (%) |
---|---|
Total | 175 (100) |
Age (years) | |
30–40 | 33 (18.9) |
41–60 | 92 (52.6) |
≥61 | 50 (28.6) |
Gender | |
Female | 55 (31.4) |
Male | 119 (68.0) |
Prefer not to respond | 1 (0.6) |
Years of post-training experience in alloHCT | |
≤10 | 61 (34.9) |
11–20 | 38 (21.7) |
>20 | 76 (43.4) |
Practice setting | |
Teaching hospital affiliated with university academic center | 150 (85.7) |
Other* | 25 (14.3) |
Annual alloHCT volume by center | |
<49 | 41 (23.4) |
50–199 | 78 (44.6) |
≥200 | 56 (32.0) |
Other practice settings by physician report included: teaching hospital not affiliated with university/academic center (n=12); non-teaching hospital (n=10); government hospital- National Institutes of Health clinical center; National Cancer Institute-designated cancer center; and office/clinic not affiliated with a hospital
Note: alloHCTs indicates allogeneic hematopoietic cell transplant